This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Hib vaccine

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Haemophilus influenzae can cause serious invasive disease, particularly in young children

  • invasive disease is usually caused by encapsulated strains of the organism
    • there are six typeable capsular serotypes (a - f) are known to cause disease
    • before the introduction of vaccination, type b (Hib) was the prevalent strain

Hib vaccine offers protection against the capsulated form of Hib that may cause:

  • meningitis
  • acute epiglottitis
  • pneumonia
  • septic arthritis
  • cellulitis

Hib-containing vaccines are made from capsular polysaccharide that has been extracted from cultures of Hib bacteria

  • the polysaccharide is linked (conjugated) to a protein - in the UK, Hib vaccines have been used that have been conjugated with either CRM197 (a non-toxic variant of diphtheria toxin) or tetanus toxoid
    • conjugation increases the immunogenicity, especially in young children in whom the plain polysaccharide vaccines are not immunogenic

The Hib vaccine is given as part of a combined product:

  • diphtheria/tetanus/acellular pertussis/inactivated polio vaccine/ Haemophilus influenzae type b (DTaP/IPV/Hib/Hep B) vaccine
  • Hib/MenC conjugate

Primary immunisation in infants and children under 10 years of age:

  • consists of three doses of a Hib-containing product with an interval of one month between each dose
    • DTaP/IPV/Hib/Hep B is recommended for all children from two months up to ten years of age
    • although one dose of Hib vaccine is effective from one year of age, three doses of DTaP/IPV/Hib should be given to children who have either not been immunised or who have not completed a primary course, in order to be fully protected against diphtheria, tetanus, pertussis and polio
    • if the primary course is interrupted it should be resumed but not repeated, allowing an interval of one month between the remaining doses
    • children of one to ten years of age who have completed a primary course of diphtheria, tetanus, pertussis and polio but have not received Hib-containing vaccines, should receive a single dose of Hib/MenC vaccine

Re-inforcing immunisation:

  • a single reinforcing (booster) dose of Hib/MenC is recommended at 12 months for children who have received a complete primary course of three Hib-containing vaccines injections
    • this booster should be given one month before pneumococcal conjugate and MMR vaccines.

Notes:

  • non-encapsulated strains are mainly associated with respiratory infections such as exacerbation of chronic bronchitis and otitis media
  • non-typeable encapsulated strains can occasionally cause invasive disease.

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 16 Haemophilis influenzae type B (Hib) (April 2019)

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.